alminoprofen has been researched along with Edema in 3 studies
alminoprofen: structure given in first source; RN given refers to parent cpd without isomeric designation
alminoprofen : A substituted aniline that is ibuprofen in which the isobutyl group is replaced by a (2-methylprop-2-en-1-yl)amino group. A non-steroidal anti-inflammatory drug, it is used for treatment of inflammatory and rheumatic disorders.
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alminoprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the phenylpropionic acid class." | 1.30 | Anti-inflammatory mechanism of alminoprofen: action on the phospholipid metabolism pathway. ( Diab, N; Domage, G; Dray, F; Mace, JL; Raguenes-Nicol, C; Russo-Marie, F; Solito, E; Streichenberger, G, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raguenes-Nicol, C | 1 |
| Russo-Marie, F | 1 |
| Domage, G | 1 |
| Diab, N | 1 |
| Solito, E | 1 |
| Dray, F | 1 |
| Mace, JL | 1 |
| Streichenberger, G | 1 |
| Kojima, E | 1 |
| Tamura, N | 1 |
| Higashide, Y | 1 |
| Lee, B | 1 |
| Yamaura, T | 2 |
| Ohnishi, H | 1 |
| Fujiyoshi, T | 1 |
| Ikeda, K | 1 |
| Saito, M | 1 |
| Iida, H | 1 |
| Maeda, E | 1 |
| Kase, N | 1 |
| Uematsu, T | 1 |
3 other studies available for alminoprofen and Edema
| Article | Year |
|---|---|
Anti-inflammatory mechanism of alminoprofen: action on the phospholipid metabolism pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyc | 1999 |
[Effects of alminoprofen on the allergic reactions].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Bronchoconstriction; | 1990 |
[The antiinflammatory effect of EB-382].
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Capillary Permeability; Cyclooxygenase I | 1986 |